Literature DB >> 14620944

Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998.

Mazaher Khodabandeh Loo1, Farzaneh Sabahi, Horieh Soleimanjdahi, Anooshirvan Kazemnejad, Mohammod Hassan Roustai.   

Abstract

Measles is an acute highly infectious viral disease. Although live attenuated vaccine is used throughout the world, outbreaks of disease still occur in many countries including Iran. In this cross-sectional study, by implementing a viral neutralization test and cell culture techniques, the seroprevalence of neutralizing anti-measles antibodies was assessed. Three hundred and fifty-four blood samples were collected and random-cluster classified from healthy subjects 6 months to 16 years old, residing in the town of Khodabandeh and its rural areas. Of the total subjects, 174 (49.2%) were girls and 180 (50.8%) were boys. From 354 subjects studied, 310 (87.6%) had neutralizing anti-measles antibody titer of 1:8 or higher and were considered to be immune and 44 (12.4%) had lower antibody titers. At the time of specimen collection, information with regards to age, sex, history of vaccination and place of residence were collected. Chi2 statistical test demonstrated a significant association between immune status and grouped age at the time of first vaccination (p < 0.009). The proportion test indicated significant differences in rate of seropositivity in paired age groups (3-8 vs. 9-11 and 9-11 vs. 12-64 months) (p < 0.02). The use of reliable techniques for assessing success of vaccination programs and performing seroepidemiological studies in order to organize national programs of control and eradication of measles are necessary.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14620944     DOI: 10.1023/a:1026104522780

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  13 in total

1.  Measles incidence, vaccine efficacy, and mortality in two urban African areas with high vaccination coverage.

Authors:  P Aaby; K Knudsen; T G Jensen; J Thårup; A Poulsen; M Sodemann; M C da Silva; H Whittle
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

2.  Seroepidemiological evaluation of 1989-91 mass vaccination campaigns against measles, in Italy.

Authors:  M E Grandolfo; E Medda; F Novello; B Ridolfi
Journal:  Epidemiol Infect       Date:  1998-12       Impact factor: 2.451

3.  Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.

Authors:  L Matter; D Germann; F Bally; K Schopfer
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

4.  Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status.

Authors:  P W Neumann; J M Weber; A G Jessamine; M V O'Shaughnessy
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

5.  A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody.

Authors:  M S Lee; B Cohen; J Hand; D J Nokes
Journal:  J Virol Methods       Date:  1999-03       Impact factor: 2.014

6.  Evaluation of an early two-dose measles vaccination schedule.

Authors:  S S Hutchins; A Dezayas; K Le Blond; J Heath; W Bellini; S Audet; J Beeler; W Wattigney; L Markowitz
Journal:  Am J Epidemiol       Date:  2001-12-01       Impact factor: 4.897

7.  Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options.

Authors:  H R Babad; D J Nokes; N J Gay; E Miller; P Morgan-Capner; R M Anderson
Journal:  Epidemiol Infect       Date:  1995-04       Impact factor: 2.451

Review 8.  Successes and failures in measles control.

Authors:  F T Cutts; L E Markowitz
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

9.  Seroepidemiology and evaluation of passive surveillance during 1988-1989 measles outbreak in Taiwan.

Authors:  M S Lee; C C King; J Y Jean; C L Kao; C C Wang; M S Ho; C J Chen; G C Lee
Journal:  Int J Epidemiol       Date:  1992-12       Impact factor: 7.196

10.  Detection and titration of measles virus antibody by hemagglutination inhibition and by dot immunobinding.

Authors:  S S Kalter; R L Heberling; J D Barry
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  1 in total

1.  Molecular Epidemiology of Measles Virus before and after the 2003 Mass Vaccination Campaign for Measles/Rubella in Iran.

Authors:  M Naseri; V Salimi; T Mokhtari-Azad; A Esteghamati; Mm Gooya; Sa Nadji; Z Noroozbabaei; Sm Marashi; Z Saadatmand; F Rezaei; R Hamkar; H Triki
Journal:  Iran J Public Health       Date:  2011-03-31       Impact factor: 1.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.